On a Mission
We are on a mission to improve and save the lives of people across the globe through the early detection of cancer, when it is most curable. These principles, “The Mercy Way”, are our true north. They shape every decision we make.
Saving lives guides our every decision
Saving lives is the most important thing, period
Numbers and money follow, they never lead
Purpose, passion, and innovation drive us
Patients are waiting
Working efficiently and with focus brings solutions to patients sooner
Saving lives guides our every decision
Our primary objective is to save lives. We are dedicated to ensuring that every decision we make contributes to our mission of making testing broadly accessible and detecting cancer early. We approach our work with a sense of urgency, knowing that patients who can benefit from early screening are waiting for us. This mission is at the center of everything we do.
Committed to continuous improvement
Pushing the boundaries of what’s possible through incremental advancement and bold breakthroughs alike
Courageously challenge conventional wisdom
A fearless curiosity and passion for discovery will uncover novel paths to achieving our vision
Boldly ambitious, grounded in science
Balancing visionary ideas with rigorous inquiry
Embrace possibility and creativity to find novel solutions
We champion “yes” then explore the “how”
Breakthroughs demand bold vision
Fearless curiosity and passion for discovery guide us to novel paths for achieving our mission. We are grounded in science and balance visionary ideas with rigorous inquiry, pushing the boundaries of what’s possible through incremental advancement and bold breakthroughs alike. With an open mind, we let go of preconceptions that impose unnecessary limits.
Always lead with humility, empathy and compassion, never ego
Our mission is fueled by collaboration, curiosity, and kindness
It’s not about WHO is right, it’s about WHAT is right
We value ideas and evidence-driven solutions, regardless of their origin
We are one team, united in our mission
Collaboration and inclusion are the keys to success
Together we will achieve
The power of teamwork is embedded in our culture. We are united in our mission to save lives, valuing ideas and evidence-driven solutions regardless of their origin. We lead with humility, empathy, and compassion, setting aside personal egos or agendas. We redefine traditional boundaries; collaboration and inclusion are the keys to success, whether inside our halls or outside our walls.
The Mercy Story
The seeds of Mercy were planted in 2010 when Paul Blavin, financier and philanthropist, met a brilliant freshman enrolled in the Blavin Scholars Program at the University of Michigan named Joseph Sedlak.
With Paul’s support, Joseph graduated summa cum laude from the University of Michigan and entered the combined MD/PhD Program at Harvard and MIT, along the way becoming Paul’s adopted son. During his graduate work, Joseph identified early detection as an area of significant unmet need in the fight to reduce cancer associated morbidity and mortality.
Together Paul and Joseph founded Mercy BioAnalytics in 2018 based on a novel idea: leveraging tumor-derived single extracellular vesicles for early cancer detection. Their mission-driven approach and commitment to creative, rigorous science has drawn a stellar group of investors, colleagues, advisors, and Board members, and the Mercy team remains steadfast in our commitment to their original vision.
The Mercy Story
The seeds of Mercy were planted in 2010 when Paul Blavin, financier and philanthropist, met a brilliant freshman enrolled in the Blavin Scholars Program at the University of Michigan named Joseph Sedlak.
With Paul’s support, Joseph graduated summa cum laude from the University of Michigan and entered the combined MD/PhD Program at Harvard and MIT, along the way becoming Paul’s adopted son. During his graduate work, Joseph identified early detection as an area of significant unmet need in the fight to reduce cancer associated morbidity and mortality.
Together Paul and Joseph founded Mercy BioAnalytics in 2018 based on a novel idea: leveraging tumor-derived single extracellular vesicles for early cancer detection. Their mission-driven approach and commitment to creative, rigorous science has drawn a stellar group of investors, colleagues, advisors, and Board members, and the Mercy team remains steadfast in our commitment to their original vision.
By focusing on rigorous science, we are pioneering globally accessible and accurate diagnostic tests to identify cancer at its earliest stages when it can be most successfully treated. This will advance the diagnostic paradigm and offer better health outcomes for more people.
If you want to go fast, go alone.
If you want to go far, go together.
African proverb
Paul and Joseph, Mercy’s co-founders, are thrilled to dedicate 1/3 of the value of their investment in Mercy BioAnalytics to the establishment of the Mercy Foundation. The foundation supports life transformation for young people who need it the most and are least able to help themselves, focusing on those that have experienced foster care, homelessness, abandonment, abuse, neglect or incarceration. This legacy of serving the underserved is at the heart of our co-founder’s personal story.